Literature DB >> 20409757

Overview of asthma; the place of the T cell.

Karim H Shalaby1, James G Martin.   

Abstract

Asthma is an inflammatory disease which is associated with activated T cells in the airway wall. The contribution of the T lymphocyte to inflammation in asthma has been extensively studied through descriptions of T cell subsets in the airway wall of asthmatic patients and from animal and cellular models. Allergy-driven airway disease is mediated primarily by the T helper (Th)2 cell subset. Other subsets, such as Th1, Th17, invariant natural killer T and CD8+ T cells likely contribute to the development, and possibly the progression of established disease. Resolution of inflammation is controlled in part by regulatory T cells. Therapies directed at T cells and their cytokines have been disappointing in asthma despite, in some instances, promising results on allergen challenge. This suggests that the induction of asthma may be T-cell-mediated and allergen-triggered, whereas disease may be sustained and exacerbated by other mechanisms. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409757     DOI: 10.1016/j.coph.2010.03.004

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  17 in total

1.  Considerations for use of acupuncture as supplemental therapy for patients with allergic asthma.

Authors:  Yong-Qing Yang; Han-Ping Chen; Yu Wang; Lei-Miao Yin; Yu-Dong Xu; Jun Ran
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

2.  CD4 and CD8 T cells require different membrane gangliosides for activation.

Authors:  Masakazu Nagafuku; Kaori Okuyama; Yuri Onimaru; Akemi Suzuki; Yuta Odagiri; Tadashi Yamashita; Katsunori Iwasaki; Michihiro Fujiwara; Motoaki Takayanagi; Isao Ohno; Jin-ichi Inokuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  Basophils as a primary inducer of the T helper type 2 immunity in ovalbumin-induced allergic airway inflammation.

Authors:  Wenwei Zhong; Wen Su; Yanjie Zhang; Qi Liu; Jinhong Wu; Caixia Di; Zili Zhang; Zhenwei Xia
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 4.  Heterogeneity of gangliosides among T cell subsets.

Authors:  Jin-ichi Inokuchi; Masakazu Nagafuku; Isao Ohno; Akemi Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-12-12       Impact factor: 9.261

5.  The effect of siRNA-mediated lymphocyte-specific protein tyrosine kinase (Lck) inhibition on pulmonary inflammation in a mouse model of asthma.

Authors:  Shikui Zhang; Rongjia Yang; Yonghua Zheng
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Increased circulating IL-9-producing CD8+ T cells are associated with eosinophilia and high FeNO in allergic asthmatics.

Authors:  Wei Wang; Zhen-Shun Cheng; Yi-Fei Chen; Yu-Hui Lin
Journal:  Exp Ther Med       Date:  2016-11-03       Impact factor: 2.447

Review 7.  Spectrum of T-lymphocyte activities regulating allergic lung inflammation.

Authors:  Erwin W Gelfand; Anthony Joetham; Meiqin Wang; Katsuyuki Takeda; Michaela Schedel
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

8.  Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation.

Authors:  Anne E Dixon; Richard E Pratley; Patrick M Forgione; David A Kaminsky; Laurie A Whittaker-Leclair; Laurianne A Griffes; Jayanthi Garudathri; Danielle Raymond; Mathew E Poynter; Janice Y Bunn; Charles G Irvin
Journal:  J Allergy Clin Immunol       Date:  2011-07-23       Impact factor: 10.793

Review 9.  Gangliosides in T cell development and function of mice.

Authors:  Jin-Ichi Inokuchi; Masakazu Nagafuku
Journal:  Glycoconj J       Date:  2022-02-14       Impact factor: 2.916

10.  CD44 variant isoforms are specifically expressed on peripheral blood lymphocytes from asthmatic patients.

Authors:  Chun Yang; Hongyan Liang; Hongli Zhao; Xiaofeng Jiang
Journal:  Exp Ther Med       Date:  2012-04-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.